Are there sleep patterns that might be a contributing factor to cancer? Or sleep habits that might help fend off cancer?
Minneapolis-based mattress company Sleep Number and the American Cancer Society (ACS) have entered a six-year partnership to study possible links between sleep and cancer.
The partnership underscores Sleep Number's ongoing strategic push into the world of sleep science, as its 360 smart bed allows customers to collect data on their own sleep patterns.
Cassie Morris joined Sleep Number in 2020 to help pilot the company's expansion into health and wellness. Morris, vice president of innovation strategy and business ventures, has a background in biomedical engineering and has worked for medtech companies including Medtronic.
Morris said that the ACS partnership is anchored by the extensive data that both organizations already have: in-depth population studies from the ACS and 13 billion hours of sleep data through customers connected to Sleep Number's SleepIQ technology.
As Sleep Number digs deeper into sleep research, it may expand into areas that allow customers to use that sleep data more.
"The way that we're thinking about it strategically is that the mattress and the sleep platform right now is not a medical device and is not intended to be," said Morris. "We are investigating additions to the portfolio that would then help intervene upon things we may find in the sleep data."
For example, Sleep Number CEO Shelly Ibach said in the company's latest earnings call: "Longer term, we are positioning Sleep Number for continued market expansion through new sleep health and wellness revenue streams, including subscription programs."